看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 3.7x - 4.0x | 3.9x |
| Historical Pb Multiple | 2.4x - 5.6x | 2.8x |
| Fair Value | ﷼133.06 - ﷼147.07 | ﷼140.06 |
| Upside | -17.0% - -8.3% | -12.7% |
| Benchmarks | - | Full Ticker |
| Middle East Healthcare Company | 400,900.0% | SASE:4009 |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 401,700.0% | SASE:4017 |
| Mouwasat Medical Services Company | 400,200.0% | SASE:4002 |
| Al Hammadi Holding Company | 400,700.0% | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 401,300.0% | SASE:4013 |
| National Medical Care Company | 400,500.0% | SASE:4005 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 4009 | 4017 | 4002 | 4007 | 4013 | 4005 | |||
| SASE:4009 | SASE:4017 | SASE:4002 | SASE:4007 | SASE:4013 | SASE:4005 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 23.6% | -0.9% | 8.9% | 29.5% | 21.6% | 30.1% | ||
| 3Y CAGR | 154.0% | -4.9% | 3.8% | 50.8% | 18.9% | 29.8% | ||
| Latest Twelve Months | 1555.1% | 2.8% | -1.8% | 11.7% | 13.2% | 23.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 4.4% | 11.9% | 26.5% | 19.5% | 19.8% | 17.5% | ||
| Prior Fiscal Year | 6.8% | 12.0% | 24.3% | 25.8% | 21.5% | 22.3% | ||
| Latest Fiscal Year | 9.8% | 10.3% | 22.4% | 29.4% | 20.7% | 23.0% | ||
| Latest Twelve Months | 9.8% | 10.3% | 22.4% | 29.4% | 20.7% | 23.0% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 7.0% | 15.9% | 22.8% | 11.1% | 28.1% | 13.8% | ||
| Prior Fiscal Year | 1.3% | 19.2% | 21.2% | 17.1% | 33.1% | 17.7% | ||
| Latest Twelve Months | 19.1% | 14.5% | 18.9% | 17.8% | 33.9% | 19.3% | ||
| Next Fiscal Year | 15.9% | 12.5% | 22.7% | 16.6% | 33.5% | 18.1% | ||
| Two Fiscal Years Forward | 16.6% | 13.1% | 20.1% | 16.1% | 36.1% | 18.9% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 2.2x | 4.1x | 5.2x | 5.8x | 8.7x | 5.6x | ||
| Price / LTM EPS | 22.4x | 39.7x | 23.2x | 19.7x | 42.1x | 24.1x | ||
| Price / Book | 3.9x | 3.9x | 4.2x | 3.4x | 13.6x | 4.4x | ||
| Price / Fwd Book | 3.3x | 3.4x | 3.7x | 3.2x | 12.1x | 4.0x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 3.4x | 3.9x | 13.6x | |||||
| Historical P/B Ratio | 2.4x | 2.8x | 5.6x | |||||
| Selected P/B Multiple | 3.7x | 3.9x | 4.0x | |||||
| (x) Book Value | 1,630 | 1,630 | 1,630 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4009 | 4017 | 4002 | 4007 | 4013 | 4005 | |
| Value of Common Equity | 6,305 | 11,408 | 15,000 | 6,664 | 97,510 | 7,194 | |
| (/) Shares Outstanding | 92.0 | 230.0 | 200.0 | 160.0 | 350.0 | 44.9 | |
| Implied Stock Price | 68.50 | 49.60 | 75.00 | 41.65 | 278.60 | 160.40 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 68.50 | 49.60 | 75.00 | 41.65 | 278.60 | 160.40 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |